Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China.
Metrics to compare | 301033 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301033PeersSector | |
---|---|---|---|---|
P/E Ratio | 57.2x | 25.4x | −0.5x | |
PEG Ratio | 0.69 | 0.63 | 0.00 | |
Price/Book | 6.9x | 2.2x | 2.6x | |
Price / LTM Sales | 17.1x | 7.4x | 3.3x | |
Upside (Analyst Target) | - | 26.1% | 43.5% | |
Fair Value Upside | Unlock | 18.9% | 6.3% | Unlock |